CONSTRUCTION AND CHARACTERIZATION OF A VI-POSITIVE VARIANT OF THE SALMONELLA-TYPHI LIVE ORAL VACCINE STRAIN TY21A

被引：17
|
作者：
CRYZ, SJ [1 ]
FURER, E [1 ]
BARON, LS [1 ]
NOON, KF [1 ]
RUBIN, FA [1 ]
KOPECKO, DJ [1 ]
机构：
[1] WALTER REED ARMY MED CTR, WASHINGTON, DC 20307 USA
来源：
INFECTION AND IMMUNITY | 1989年 / 57卷 / 12期
关键词：
D O I：
10.1128/IAI.57.12.3863-3868.1989
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：3863 / 3868
页数：6
相关论文
共 50 条
  • [41] IMMUNOGENICITY OF TY21A ATTENUATED SALMONELLA-TYPHI GIVEN WITH SODIUM-BICARBONATE OR IN ENTERIC-COATED CAPSULES
    BLACK, R
    LEVINE, MM
    YOUNG, C
    ROONEY, J
    LEVINE, S
    CLEMENTS, ML
    ODONNELL, S
    HUGUES, T
    GERMANIER, R
    DEVELOPMENTS IN BIOLOGICALS, 1982, 53 : 9 - 14
  • [42] A case report of anaphylaxis to Typhoid Vaccine Live Oral Ty21a (Vivotif)
    Haas, Nathan L.
    Haas, Mary R. C.
    Gregory, Charmaine
    JOURNAL OF TRAVEL MEDICINE, 2017, 24 (05)
  • [43] ENTEROADHESION FIMBRIAE AND ENTERO-TOXIN OF ESCHERICHIA-COLI - GENETIC TRANSFER TO A STREPTOMYCIN-RESISTANT MUTANT OF THE GALE ORAL-ROUTE LIVE-VACCINE SALMONELLA-TYPHI TY21A
    YAMAMOTO, T
    TAMURA, Y
    YOKOTA, T
    INFECTION AND IMMUNITY, 1985, 50 (03) : 925 - 928
  • [44] Longevity of duodenal and peripheral T-cell and humoral responses to live-attenuated Salmonella Typhi strain Ty21a
    Pennington, Shaun H.
    Ferreira, Daniela M.
    Reine, Jesus
    Nyirenda, Tonney S.
    Thompson, Ameeka L.
    Hancock, Carole A.
    Wright, Angela D.
    Gordon, Stephen B.
    Gordon, Melita A.
    VACCINE, 2018, 36 (31) : 4725 - 4733
  • [45] INVITRO CHARACTERIZATION OF SALMONELLA-TYPHI MUTANT STRAINS FOR LIVE ORAL VACCINES
    DRAGUNSKY, EM
    RIVERA, E
    HOCHSTEIN, HD
    LEVENBOOK, IS
    VACCINE, 1990, 8 (03) : 263 - 268
  • [46] EVALUATION IN VOLUNTEERS OF A CANDIDATE LIVE ORAL ATTENUATED SALMONELLA-TYPHI VECTOR VACCINE
    HONE, DM
    TACKET, CO
    HARRIS, AM
    KAY, B
    LOSONSKY, G
    LEVINE, MM
    JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (02): : 412 - 420
  • [47] CELLULAR-IMMUNITY AGAINST SALMONELLA-TYPHI AFTER LIVE ORAL VACCINE
    TAGLIABUE, A
    NENCIONI, L
    CAFFARENA, A
    VILLA, L
    BORASCHI, D
    CAZZOLA, G
    CAVALIERI, S
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1985, 62 (02): : 242 - 247
  • [48] Compliance to live oral Ty21a typhoid vaccine, and its effect on viability
    Stubi, CLF
    Landry, PR
    Pétignat, C
    Blaise, JB
    Genton, B
    Darioli, R
    Burnier, M
    JOURNAL OF TRAVEL MEDICINE, 2000, 7 (03) : 133 - 137
  • [49] SAFETY, IMMUNOGENICITY, AND EFFICACY AGAINST CHOLERA CHALLENGE IN HUMANS OF A TYPHOID-CHOLERA HYBRID VACCINE DERIVED FROM SALMONELLA-TYPHI TY21A
    TACKET, CO
    FORREST, B
    MORONA, R
    ATTRIDGE, SR
    LABROOY, J
    TALL, BD
    REYMANN, M
    ROWLEY, D
    LEVINE, MM
    INFECTION AND IMMUNITY, 1990, 58 (06) : 1620 - 1627
  • [50] Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica serovar paratyphi B
    Levine, Myron M.
    Ferreccio, Catterine
    Black, Robert E.
    Lagos, Rosanna
    Martin, Oriana San
    Blackwelder, William C.
    CLINICAL INFECTIOUS DISEASES, 2007, 45 : S24 - S28
12345